WEST LAFAYETTE, Ind.--(BUSINESS WIRE)--Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will report financial results for the second quarter of fiscal 2016 ended March 31, 2016, prior to the market opening on Thursday, May 12, 2016. A conference call has been scheduled at 11:00 a.m. Eastern Daylight Time (EDT) to discuss the results. To participate in the call, dial (866) 865-2633, using Conference ID 5431136.
A simultaneous webcast of the conference call may be accessed online from the Investors tab at www.BASinc.com. The webcast will be available for replay after 2:00 p.m. EDT at this same internet address for a telephone replay, dial (855) 859-2056 from May 12th through May 19th.
About Bioanalytical Systems, Inc.
BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASinc.com for more about BASi.
This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings with the Securities and Exchange Commission.